Mentioned On
Episode Mentions
Pharma and BioTech Daily · Jul 28, 2026
AstraZeneca's $80B Target Amid Setbacks? | Pharma and Biotech Daily
“Acquired by Argenix; developing phase 2 vitiligo drug”
Antibody-Drug Conjugates (ADCs) in OncologyNon-Stimulant ADHD TherapeuticsDuchenne Muscular Dystrophy (DMD) Treatments
View AnalysisStock Movers · Jul 10, 2026
Weekly Roundup: Meta's Big Week, Paramount Skydance Mixed, Forte Biosciences Soars
“Surged 110% on positive early-stage clinical data for vitiligo drug; best week since 2024”
Meta AI Competitive PositioningLarge Language Model CompetitionMedia Merger Debt Management
View Analysis